SEARCH

SEARCH BY CITATION

References

  • Almaas R., Pytte M., Lindstad J. K., Wright M., Saugstad O. D., Pleasure D. and Rootwelt T. (2003) Acidosis has opposite effects on neuronal survival during hypoxia and reoxygenation. J. Neurochem. 84, 10181027.
  • Almeida S., Domingues A., Rodrigues L., Oliveira C. R. and Rego A. C. (2004) FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. Neurobiol. Dis. 17, 435444.
  • Anderson R. E., Tan W. K., Martin H. S. and Meyer F. B. (1999) Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 30, 160170.
  • Antonini B., Piva S., Paltenghi M., Candiani A. and Latronico N. (2008) The early phase of critical illness is a progressive acidic state due to unmeasured anions. Eur. J. Anaesthesiol. 25, 566571.
  • Baek S. H., Kim J. Y., Choi J. H., Park E. M., Han M. Y., Kim C. H., Ahn Y. S. and Park Y. M. (2000) Reduced glutathione oxidation ratio and 8 ohdG accumulation by mild ischemic pretreatment. Brain Res. 856, 2836.
  • Bannai S. and Kitamura E. (1981) Role of proton dissociation in the transport of cystine and glutamate in human diploid fibroblasts in culture. J. Biol. Chem. 256, 57705772.
  • Bates D. J., Lively M. O., Gorczynski M. J., King S. B., Townsend A. J. and Morrow C. S. (2009) Noncatalytic interactions between glutathione S-transferases and nitroalkene fatty acids modulate nitroalkene-mediated activation of peroxisomal proliferator-activated receptor gamma. Biochemistry 48, 41594169.
  • Blair I. A. (2006) Endogenous glutathione adducts. Curr. Drug Metab. 7, 853872.
  • Capes S. E., Hunt D., Malmberg K., Pathak P. and Gerstein H. C. (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32, 24262432.
  • Chiueh C. C. and Rauhala P. (1999) The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic. Res. 31, 641650.
  • Choi D. W. (1987) Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7, 369379.
  • Crimi E., Sica V., Williams-Ignarro S., Zhang H., Slutsky A. S., Ignarro L. J. and Napoli C. (2006) The role of oxidative stress in adult critical care. Free Radic. Biol. Med. 40, 398406.
  • Davis J. B. and Maher P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652, 169173.
  • Drake J., Kanski J., Varadarajan S., Tsoras M. and Butterfield D. A. (2002) Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J. Neurosci. Res. 68, 776784.
  • Dringen R. and Hirrlinger J. (2003) Glutathione pathways in the brain. Biol. Chem. 384, 505516.
  • Folbergrova J., Zhao Q., Katsura K. and Siesjo B. K. (1995) N-tert-Butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc. Natl Acad. Sci. USA 92, 50575061.
  • Friese M. A., Craner M. J., Etzensperger R., Vergo S., Wemmie J. A., Welsh M. J., Vincent A. and Fugger L. (2007) Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat. Med. 13, 14831489.
  • Giffard R. G., Monyer H., Christine C. W. and Choi D. W. (1990) Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen–glucose deprivation neuronal injury in cortical cultures. Brain Res. 506, 339342.
  • Gonsette R. E. (2008) Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J. Neurol. Sci. 274, 4853.
  • Hansen M. B., Nielsen S. E. and Berg K. (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203210.
  • Ikonomidou C. and Turski L. (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383386.
  • Ishige K., Chen Q., Sagara Y. and Schubert D. (2001a) The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J. Neurosci. 21, 60696076.
  • Ishige K., Schubert D. and Sagara Y. (2001b) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 30, 433446.
  • Katsura K., Kristian T., Smith M. L. and Siesjo B. K. (1994) Acidosis induced by hypercapnia exaggerates ischemic brain damage. J. Cereb. Blood Flow Metab. 14, 243250.
  • Kochhar A., Zivin J. A., Lyden P. D. and Mazzarella V. (1988) Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch. Neurol. 45, 148153.
  • Koyama Y., Kimura Y., Hashimoto H., Matsuda T. and Baba A. (2000) l-Lactate inhibits l-cystine/l-glutamate exchange transport and decreases glutathione content in rat cultured astrocytes. J. Neurosci. Res. 59, 685691.
  • Kraig R. P., Petito C. K., Plum F. and Pulsinelli W. A. (1987) Hydrogen ions kill brain at concentrations reached in ischemia. J. Cereb. Blood Flow Metab. 7, 379386.
  • Lewerenz J. and Maher P. (2009) Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J. Biol. Chem. 284, 11061115.
  • Lewerenz J., Letz J. and Methner A. (2003) Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress. J. Neurochem. 87, 522531.
  • Lewerenz J., Albrecht P., Tien M. L., Henke N., Karumbayaram S., Kornblum H. I., Wiedau-Pazos M., Schubert D., Maher P. and Methner A. (2009) Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J. Neurochem. 111, 332343.
  • Li P. A., Shamloo M., Katsura K., Smith M. L. and Siesjo B. K. (1995) Critical values for plasma glucose in aggravating ischaemic brain damage: correlation to extracellular pH. Neurobiol Dis 2, 97108.
  • Li Y., Maher P. and Schubert D. (1997a) Requirement for cGMP in nerve cell death caused by glutathione depletion. J. Cell Biol. 139, 13171324.
  • Li Y., Maher P. and Schubert D. (1997b) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453463.
  • Liu Y., Dargusch R., Maher P. and Schubert D. (2008) A broadly neuroprotective derivative of curcumin. J. Neurochem. 105, 13361345.
  • Lo H. W. and Ali-Osman F. (2007) Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr. Opin. Pharmacol. 7, 367374.
  • Maher P. (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J. Neurosci. 21, 29292938.
  • Maher P. (2005) The effects of stress and aging on glutathione metabolism. Ageing Res. Rev. 4, 288314.
  • Maher P. (2006) A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives. Free Radic. Res. 40, 11051111.
  • Maher P. and Davis J. B. (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16, 63946401.
  • Maher P. and Hanneken A. (2005) Flavonoids protect retinal ganglion cells from oxidative stress-induced death. Invest. Ophthalmol. Vis. Sci. 46, 47964803.
  • Maher P., Salgado K. F., Zivin J. A. and Lapchak P. A. (2007) A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res. 1173, 117125.
  • Mandeles S. and Block K. (1955) Enzymatic synthesis of gamma-glutamylcysteine. J. Biol. Chem. 214, 639646.
  • Meister A. (1963) Biochemistry of the Amino Acids. Academic Press, New York.
  • Miyamoto M., Murphy T. H., Schnaar R. L. and Coyle J. T. (1989) Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250, 11321140.
  • Murphy T. H., Schnaar R. L. and Coyle J. T. (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4, 16241633.
  • Nedergaard M., Kraig R. P., Tanabe J. and Pulsinelli W. A. (1991) Dynamics of interstitial and intracellular pH in evolving brain infarct. Am. J. Physiol. 260, R581R588.
  • Pabst M. J., Habig W. H. and Jakoby W. B. (1974) Glutathione S-transferase A. A novel kinetic mechanism in which the major reaction pathway depends on substrate concentration. J. Biol. Chem. 249, 71407147.
  • Park C. K., Nehls D. G., Graham D. I., Teasdale G. M. and McCulloch J. (1988) The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24, 543551.
  • Parsons M. W., Barber P. A., Desmond P. M., Baird T. A., Darby D. G., Byrnes G., Tress B. M. and Davis S. M. (2002) Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann. Neurol. 52, 2028.
  • Perez-Pinzon M. A., Maier C. M., Yoon E. J., Sun G. H., Giffard R. G. and Steinberg G. K. (1995) Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15, 865876.
  • Raftos J. E., Whillier S., Chapman B. E. and Kuchel P. W. (2007) Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes. Int. J. Biochem. Cell Biol. 39, 16981706.
  • Ratan R. R., Murphy T. H. and Baraban J. M. (1994) Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J. Neurosci. 14, 43854392.
  • Rinaldi R., Eliasson E., Swedmark S. and Morgenstern R. (2002) Reactive intermediates and the dynamics of glutathione transferases. Drug Metab. Dispos. 30, 10531058.
  • Rivera F., Urbanavicius J., Gervaz E., Morquio A. and Dajas F. (2004) Some aspects of the in vivo neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship. Neurotox. Res. 6, 543553.
  • Rytter A., Cronberg T., Asztely F., Nemali S. and Wieloch T. (2003) Mouse hippocampal organotypic tissue cultures exposed to in vitro “ischemia” show selective and delayed CA1 damage that is aggravated by glucose. J. Cereb. Blood Flow Metab. 23, 2333.
  • Sagara Y., Dargusch R., Chambers D., Davis J., Schubert D. and Maher P. (1998) Cellular mechanisms of resistance to chronic oxidative stress. Free Radic. Biol. Med. 24, 13751389.
  • Sagara Y., Ishige K., Tsai C. and Maher P. (2002) Tyrphostins protect neuronal cells from oxidative stress. J. Biol. Chem. 277, 3620436215.
  • Sahin M., Saxena A., Joost P., Lewerenz J. and Methner A. (2006) Induction of Bcl-2 by functional regulation of G-protein coupled receptors protects from oxidative glutamate toxicity by increasing glutathione. Free Radic. Res. 40, 11131123.
  • Schafer F. Q. and Buettner G. R. (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30, 11911212.
  • Schubert D. and Piasecki D. (2001) Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J. Neurosci. 21, 74557462.
  • Shih A. Y., Li P. and Murphy T. H. (2005) A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J. Neurosci. 25, 1032110335.
  • Shivakumar B. R., Kolluri S. V. and Ravindranath V. (1995) Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia. J. Pharmacol. Exp. Ther. 274, 11671173.
  • Siesjo B. K., Katsura K. and Kristian T. (1996) Acidosis-related damage. Adv. Neurol. 71, 209233; discussion 234–206.
  • Snoke J. E., Yanari S. and Bloch K. (1953) Synthesis of glutathione from gamma-glutamylcysteine. J. Biol. Chem. 201, 573586.
  • Tan S., Sagara Y., Liu Y., Maher P. and Schubert D. (1998a) The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141, 14231432.
  • Tan S., Wood M. and Maher P. (1998b) Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71, 95105.
  • Tan S., Schubert D. and Maher P. (2001) Oxytosis: A novel form of programmed cell death. Curr. Top. Med. Chem. 1, 497506.
  • Tang C. M., Dichter M. and Morad M. (1990) Modulation of the N-methyl-D-aspartate channel by extracellular H+. Proc. Natl Acad. Sci. USA 87, 64456449.
  • Tombaugh G. C. and Sapolsky R. M. (1990) Mild acidosis protects hippocampal neurons from injury induced by oxygen and glucose deprivation. Brain Res. 506, 343345.
  • Vantyghem M. C., Balduyck M., Zerimech F., Martin A., Douillard C., Bans S., Degand P. M. and Lefebvre J. (2000) Oxidative markers in diabetic ketoacidosis. J. Endocrinol. Invest. 23, 732736.
  • Wagner K. R., Kleinholz M., De Courten-Myers G. M. and Myers R. E. (1992) Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular pH, and infarct size. J. Cereb. Blood Flow Metab. 12, 213222.
  • Weisbrot-Lefkowitz M., Reuhl K., Perry B., Chan P. H., Inouye M. and Mirochnitchenko O. (1998) Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Brain Res. 53, 333338.
  • Widmer H., Abiko H., Faden A. I., James T. L. and Weinstein P. R. (1992) Effects of hyperglycemia on the time course of changes in energy metabolism and pH during global cerebral ischemia and reperfusion in rats: correlation of 1H and 31P NMR spectroscopy with fatty acid and excitatory amino acid levels. J. Cereb. Blood Flow Metab. 12, 456468.
  • Williams L. S., Rotich J., Qi R., Fineberg N., Espay A., Bruno A., Fineberg S. E. and Tierney W. R. (2002) Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59, 6771.
  • Ying W., Han S. K., Miller J. W. and Swanson R. A. (1999) Acidosis potentiates oxidative neuronal death by multiple mechanisms. J. Neurochem. 73, 15491556.